Logos Global Management LP Design Therapeutics, Inc. Transaction History
Logos Global Management LP
- $1.07 Billion
- Q2 2024
A detailed history of Logos Global Management LP transactions in Design Therapeutics, Inc. stock. As of the latest transaction made, Logos Global Management LP holds 5,032,501 shares of DSGN stock, worth $27.2 Million. This represents 1.58% of its overall portfolio holdings.
Number of Shares
5,032,501
Previous 5,032,501
-0.0%
Holding current value
$27.2 Million
Previous $16.9 Million
-0.0%
% of portfolio
1.58%
Previous 1.58%
Shares
4 transactions
Others Institutions Holding DSGN
# of Institutions
100Shares Held
31.9MCall Options Held
1.1KPut Options Held
21.3K-
Sr One Capital Management, LP6.53MShares$35.3 Million9.6% of portfolio
-
Black Rock Inc. New York, NY2.3MShares$12.5 Million0.0% of portfolio
-
Baker Bros. Advisors LP New York, NY1.7MShares$9.17 Million0.08% of portfolio
-
Tang Capital Management LLC San Diego, CA1.48MShares$8.01 Million0.61% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.3MShares$7.02 Million0.0% of portfolio
About Design Therapeutics, Inc.
- Ticker DSGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,807,900
- Market Cap $302M
- Description
- Design Therapeutics, Inc. a preclinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of genetic diseases caused by nucleotide repeat expansions. The company's portfolio of products comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ syste...